✦ LIBER ✦

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

✍ Scribed by Yoshihiro Noji; Toshinori Higashikata; Akihiro Inazu; Atsushi Nohara; Kosei Ueda; Susumu Miyamoto; Kouji Kajinami; Tadayoshi Takegoshi; Junji Koizumi; Hiroshi Mabuchi

Book ID: 119435547
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 108 KB
Volume: 163
Category: Article
ISSN: 0021-9150
DOI: 10.1016/s0021-9150(01)00765-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effects of NK-104 (itavastatin

Long-term effects of NK-104 (itavastatin), a new HMG-CoA reductase inhibitor, in patients with heterozygous familial hypercholesterolemia

✍ H Mabuchi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A long-term comparative trial of cerivas

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

✍ Jun Sasaki; Kikuo Arakawa; Kyosuke Yamamoto; Shozo Kobori; Masato Ageta; Suminor 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Additive effects of another kind of HMG-

Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia

✍ Tsuyoshi Nozue; Atsushi Nohara; Toshinori Higashikata; Akihiro Inazu; Hiroshi Ma 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 49 KB

High density lipoprotein cholesterol and

High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor

✍ Tatsuya Fukutomi; Yutaka Takeda; Shogo Suzuki; Tatsuya Ito; Takashi Joh; Makoto 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Effects of cerivastatin sodium, a new HM

Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia

✍ Susumu Tazuma; Gunji Yamashita; Hidenori Ochi; Hiroyuki Miura; Tsuyoshi Kajihara 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Efficacy and safety of a new HMG-CoA red

Efficacy and safety of a new HMG-CoA reductase inhibitor, NK-104, in patients with hypertriglyceridemia — Randomized double-blind, cross-over placebo controlled study

✍ J Sasaki; Y Ikeda; K Yamamoto; M Ageta; K Arakawa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 134 KB